A Prospective Multicenter Non-interventional Study of Women Treated With ESMYA (Ulipristal Acetate) as Pre-operative Treatment of Moderate to Severe Symptoms of Uterine Fibroids (PREMYA)
Phase of Trial: Phase IV
Latest Information Update: 06 Jan 2017
At a glance
- Drugs Ulipristal (Primary)
- Indications Uterine leiomyoma
- Focus Adverse reactions; Registrational
- Acronyms PREMYA
- Sponsors PregLem
- 26 Jan 2015 Planned End Date changed from 1 Dec 2014 to 1 Mar 2016 as reported by ClinicalTrials.gov record.
- 26 Jan 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 17 Dec 2012 New source identified and integrated (United Kingdom Clinical Research Network, 12878).